Advancing radiation oncology through scientific publication - 100 volumes of Radiotherapy and Oncology

Radiotherapy and Oncology

Volumn 100, Issue 1, 2011, Pages 1-6

  Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL EDUCATION; MEDICAL SOCIETY; PEER REVIEW; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REVIEW; SCIENTIFIC LITERATURE;

EID: 80051780602     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.07.011     Document Type: Editorial

References (162)

1. Tubiana M. Presidential address. Radiother Oncol 1983; 1: X. (see Supplementary material).
2. LENT SOMA tables. Radiother Oncol 1995;35:17-60.
3. M. Nordsmark, M. Overgaard, and J. Overgaard Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother Oncol 41 1996 31 39 (Pubitemid 26396294)
4. M. Höckel, C. Knoop, and K. Schlenger Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix Radiother Oncol 26 1993 45 50 (Pubitemid 23063609)
5. J.L. Wike-Hooley, J. Haveman, and H.S. Reinhold The relevance of tumour pH to the treatment of malignant disease Radiother Oncol 2 1984 343 366 (Pubitemid 15166545)
6. J.C. Horiot, R. Le Fur, and T. N'Guyen Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Radiother Oncol 25 1992 231 241 (Pubitemid 23000765)
7. A.W. Fyles, M. Milosevic, and R. Wong Oxygenation predicts radiation response and survival in patients with cervix cancer Radiother Oncol 48 1998 149 156 (Pubitemid 28423786)
8. J. Deacon, M.J. Peckham, and G.G. Steel The radioresponsiveness of human tumours and the initial slope of the cell survival curve Radiother Oncol 2 1994 317 323
9. D. Sarrazin, M.G. Lê, and R. Arriagada Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer Radiother Oncol 14 1989 177 184 (Pubitemid 19087084)
10. J.C. Horiot, P. Bontemps, and W. van den Bogaert Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial Radiother Oncol 44 1997 111 121 (Pubitemid 27345198)
11. S. Dische, M. Saunders, A. Barrett, A. Harvey, D. Gibson, and M. Parmar A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer Radiother Oncol 44 1997 123 136 (Pubitemid 27345199)
12. J. Bussink, J.H. Kaanders, and A.J. van der Kogel Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers Radiother Oncol 67 2003 3 15 (Pubitemid 36575463)
13. J. Overgaard Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis Radiother Oncol 100 2011 22 32
14. J. Overgaard Hypoxic radiosensitization: adored and ignored J Clin Oncol 25 2007 4066 4074 (Pubitemid 47492951)
15. M.R. Horsman, D.J. Chaplin, and J. Overgaard Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells Cancer Res 50 1990 7430 7436
16. R. Murata, D.W. Siemann, J. Overgaard, and M.R. Horsman Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors Radiother Oncol 60 2001 155 161 (Pubitemid 32601968)
17. S.M. Bentzen, I. Balslev, and M. Pedersen Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis Br J Cancer 65 1992 102 107
18. D. De Ruysscher, C. Dehing, and S.M. Bentzen P. Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis- generating study Radiother Oncol 93 2009 389 395
19. P. Lassen The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome Radiother Oncol 95 2010 371 380
20. M. Overgaard, H.M. Nielsen, and J. Overgaard Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials Radiother Oncol 82 2007 247 253 (Pubitemid 46350797)
21. M. Mannino, and J. Yarnold Accelerated partial breast irradiation trials: diversity in rationale and design Radiother Oncol 91 2009 16 22
22. C.N. Andreassen, J. Alsner, and J. Overgaard TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer Radiother Oncol 75 2005 18 21 (Pubitemid 40616789)
23. B.V. Offersen, M. Overgaard, N. Kroman, and J. Overgaard Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review Radiother Oncol 90 2009 1 13
24. B. Berger, and C. Belka Evidence-based radiation oncology: oesophagus Radiother Oncol 92 2009 276 290
25. V. Valentini, R. Beets-Tan, and J.M. Borras Evidence and research in rectal cancer Radiother Oncol 87 2008 449 474
26. R. Corv Evidence-based radiation oncology in head and neck squamous cell carcinoma Radiother Oncol 5 2007 156 170
27. V. Grégoire, P. Levendag, and K.K. Ang CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines Radiother Oncol 69 2003 227 236 (Pubitemid 37485996)
28. R. Pötter, C. Haie-Meder, and E. Van Limbergen Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77 (Pubitemid 43131038)
29. O. Zgheib, Y. Huyen, and R.A. DiTullio Jr ATM signaling and 53BP1 Radiother Oncol 76 2005 119 122 (Pubitemid 41725436)
30. J.P. Pignon, A. le Maître, and E. Maillard Bourhis J; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients Radiother Oncol 92 2009 4 14
31. C. Haie-Meder, R. Pötter, and E. Van Limbergen Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV Radiother Oncol 74 2005 235 245 (Pubitemid 40349132)
32. V. Grégoire, A. Eisbruch, M. Hamoir, and P. Levendag Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck Radiother Oncol 79 2006 15 20
33. A. Trotti, L.A. Bellm, and J.B. Epstein Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review Radiother Oncol 66 2003 253 262 (Pubitemid 36556043)
34. O. Feron Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells Radiother Oncol 92 2009 329 333
35. D. Boehmer, P. Maingon, and P. Poortmans EORTC radiation oncology group. Guidelines for primary radiotherapy of patients with prostate cancer Radiother Oncol 79 2006 259 269 (Pubitemid 44109911)
36. V. Grégoire, E. Coche, G. Cosnard, M. Hamoir, and H. Reychler Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience Radiother Oncol 56 2000 135 150 (Pubitemid 30601670)
37. C. Giro, B. Berger, and E. Bolke High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes Radiother Oncol 90 2009 166 171
38. J.P. Pignon, A. le Maitre, and E. Maillard Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17, 346 patients Radiother Oncol 92 2009 4 14
39. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
40. E. Vanetti, A. Clivio, and G. Nicolini Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: A treatment planning comparison with fixed field IMRT Radiother Oncol 92 2009 111 117
41. A. Clivio, A. Fogliata, and A. Franzetti-Pellanda Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT Radiother Oncol 92 2009 118 124
42. M. Tubiana Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review Radiother Oncol 91 2009 4 15
43. C. Fiorino, R. Valdagni, and T. Rancati Dose-volume effects for normal tissues in external radiotherapy: Pelvis Radiother Oncol 93 2009 153 167
44. V. Valentini, C. Aristei, and B. Glimelius Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2) Radiother Oncol 92 2009 148 163
45. W.F.A.R. Verbakel, S. Senan, and J.P. Cuijpers Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs Radiother Oncol 93 2009 122 124
46. S.M. Bentzen Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy Radiother Oncol 46 1998 5 18 (Pubitemid 28072852)
47. J. Overgaard, and S.M. Bentzen Evidence based radiation oncology Radiother Oncol 46 1998 1 3 (Pubitemid 28072851)
48. D. Thwaites, P. Scalliet, J.W. Leer, and J. Overgaard Quality assurance in radiotherapy. European Society for Therapeutic Radiology and Oncology Advisory Report to the Commission of the European Union for the 'Europe Against Cancer Programme' Radiother Oncol 35 1995 61 73
49. S. Hehlgans, I. Lange, I. Eke, and N. Cordes 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226 Radiother Oncol 92 2009 371 378
50. M. Busk, M.R. Horsman, and S. Jakobsen Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol 92 2009 429 436
51. H. Mujcic, T. Rzymski, and K.M. Rouschop Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3 Radiother Oncol 92 2009 450 459
52. H.P. Rodemann Molecular radiation biology: perspectives for radiation oncology Radiother Oncol 92 2009 293 298
53. C. Dittfeld, A. Dietrich, and S. Peickert CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116 Radiother Oncol 92 2009 353 361
54. O. Riesterer, K.A. Mason, and U. Raju Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed Radiother Oncol 92 2009 383 387
55. C.N. Andreassen, and J. Alsner Genetic variants and normal tissue toxicity after radiotherapy: a systematic review Radiother Oncol 92 2009 299 309
56. A. Yaromina, A. Eckardt, and D. Zips Core needle biopsies for determination of the microenvironment in individual tumours for longitudinal radiobiological studies Radiother Oncol 92 2009 460 465
57. S. Hehlgans, I. Eke, K. Storch, M. Haase, G.B. Baretton, and N. Cordes Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells Radiother Oncol 92 2009 362 370
58. J. Feng, M. van der Zwaag, M.A. Stokman, R. van Os, and R.P. Coppes Isolation and characterization of human salivary gland cells for stem cell transplantation to reduce radiation-induced hyposalivation Radiother Oncol 92 2009 466 471
59. K.M. Rouschop, and C.H. Ramaekers Autophagy is required during cycling hypoxia to lower production of reactive oxygen species Radiother Oncol 92 2009 411 416
60. B. Jutten, L. Dubois, and Y. Li Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells Radiother Oncol 92 2009 393 398
61. J.A. Bonner, H.Q. Trummell, C.D. Willey, B.A. Plants, and K.P. Raisch Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma Radiother Oncol 92 2009 339 344
62. L. Dubois, N.G. Lieuwes, and A. Maresca Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model Radiother Oncol 92 2009 423 428
63. J. Theys, B. Jutten, and L. Dubois The deletion mutant EGFRvIII significantly contributes to stress resistance typical for the tumour microenvironment Radiother Oncol 92 2009 399 404
64. C. Ostrau, J. Hülsenbeck, and M. Herzog Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo Radiother Oncol 92 2009 492 499
65. M.H. Starmans, D. Zips, B.G. Wouters, M. Baumann, and P. Lambin The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response Radiother Oncol 92 2009 417 422
66. T. van den Beucken, C.H. Ramaekers, K. Rouschop, M. Koritzinsky, and B.G. Wouters Deficient carbonic anhydrase 9 expression in UPR-impaired cells is associated with reduced survival in an acidic microenvironment Radiother Oncol 92 2009 437 442
67. R.E. Meyn, A. Munshi, J.V. Haymach, L. Milas, and K.K. Ang Receptor signaling as a regulatory mechanism of DNA repair Radiother Oncol 92 2009 316 322
68. G. Iliakis Backup pathways of NHEJ in cells of higher eukaryotes: cell cycle dependence Radiother Oncol 92 2009 310 315
69. M. Scharpfenecker, B. Floot, N.S. Russell, P. Ten Dijke, and F.A. Stewart Endoglin haploinsufficiency reduces radiation-induced fibrosis and telangiectasia formation in mouse kidneys Radiother Oncol 92 2009 484 491
70. J. Haagen, H. Krohn, S. Röllig, M. Schmidt, K. Wolfram, and W. Dörr Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies Radiother Oncol 92 2009 472 476
71. K. Dittmann, C. Mayer, R. Kehlbach, M.C. Rothmund, and H. Peter Rodemann Radiation-induced lipid peroxidation activates src kinase and triggers nuclear EGFR transport Radiother Oncol 92 2009 379 382
72. N.S. Russell, S. Hoving, and S. Heeneman Novel insights into pathological changes in muscular arteries of radiotherapy patients Radiother Oncol 92 2009 477 483
73. D.A. Gewirtz, M.L. Hilliker, and E.N. Wilson Promotion of autophagy as a mechanism for radiation sensitization of breast tumor cells Radiother Oncol 92 2009 323 328
74. B.S. Sørensen, M.R. Horsman, H. Vorum, B. Honoré, J. Overgaard, and J. Alsner Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics Radiother Oncol 92 2009 443 449
75. N. Zhang, K. Erjala, and J. Kulmala Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro Radiother Oncol 92 2009 388 392
76. A.E. Para, A. Bezjak, I.W. Yeung, J. Van Dyk, and R.P. Hill Effects of genistein following fractionated lung irradiation in mice Radiother Oncol 92 2009 500 510
77. L. Xing, X. Sun, X. Deng, and K. Kotedia Expression of the bifunctional suicide gene CDUPRT increases radiosensitization and bystander effect of 5-FC in prostate cancer cells Radiother Oncol 92 2009 345 352
78. D. Zips, K. Le, and A. Yaromina Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas Radiother Oncol 92 2009 405 410
79. D. Sebag-Montefiore, K. Bujko, and V. Valentini Rectal cancer multidisciplinary management: evidences and future landscape Radiother Oncol 92 2009 145 147
80. D.I. Thwaites, and D. Verellen Vorsprung durch Technik: evolution, implementation, QA and safety of new technology in radiotherapy Radiother Oncol 94 2010 125 128
81. S. Korreman, C. Rasch, and H. McNair The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide Radiother Oncol 94 2010 129 144
82. K. Tanderup, S.K. Nielsen, and G.B. Nyvang From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer Radiother Oncol 94 2010 173 180
83. A. Fredh, S. Korreman, and P.M. Rosenschöld Automated analysis of images acquired with electronic portal imaging device during delivery of quality assurance plans for inversely optimized arc therapy Radiother Oncol 94 2010 195 198
84. I.T. Kuijper, M. Dahele, S. Senan, and W.F. Verbakel Volumetric modulated arc therapy versus conventional intensity modulated radiation therapy for stereotactic spine radiotherapy: a planning study and early clinical data Radiother Oncol 94 2010 224 228
85. S. Broggi, C. Fiorino, and I. Dell'Oca A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer Radiother Oncol 94 2010 206 212
86. G. Groenendaal, M.R. Moman, and J.G. Korporaal Validation of functional imaging with pathology for tumor delineation in the prostate Radiother Oncol 94 2010 145 150
87. M.H. Janssen, M.C. Ollers, and R.G. van Stiphout Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings Radiother Oncol 94 2010 151 155
88. M. Ahmed, M. Schmidt, and A. Sohaib The value of magnetic resonance imaging in target volume delineation of base of tongue tumours - a study using flexible surface coils Radiother Oncol 94 2010 161 167
89. S.L. Gulliford, M. Partridge, M.R. Sydes, J. Andreyev, and D.P. Dearnaley A comparison of dose-volume constraints derived using peak and longitudinal definitions oflate rectal toxicity Radiother Oncol 94 2010 241 247
90. E. Sterpin, B.T. Hundertmark, T.R. Mackie, W. Lu, G.H. Olivera, and S. Vynckier Monte Carlo-based analytical model for small and variable fields delivered by TomoTherapy Radiother Oncol 94 2010 229 234
91. J.G. Korporaal, C.A. van den Berg, G. Groenendaal, M.R. Moman, M. van Vulpen, and U.A. van der Heide The use of probability maps to deal with the uncertainties in prostate cancer delineation Radiother Oncol 94 2010 168 172
92. A. Mans, P. Remeijer, and I. Olaciregui-Ruiz 3D Dosimetric verification of volumetric-modulated arc therapy by portal dosimetry Radiother Oncol 94 2010 181 187
93. M. Falk, P.M. af Rosenschöld, P. Keall, J. Zimmerman, and S. Korreman Real-time dynamic MLC tracking for inversely optimized arc radiotherapy Radiother Oncol 94 2010 218 223
94. S. van Beek, S. van Kranen, and A. Mencarelli First clinical experience with a multiple region of interest registration and correction method in radiotherapy of head-and-neck cancer patients Radiother Oncol 94 2010 213 217
95. W. van Elmpt, S. Petit, D. De Ruysscher, P. Lambin, and A. Dekker 3D dose delivery verification using repeated cone-beam imaging and EPID dosimetry for stereotactic body radiotherapy of non-small cell lung cancer Radiother Oncol 94 2010 188 194
96. S. van Kranen, S. van Beek, A. Mencarelli, C. Rasch, M. van Herk, and J.J. Sonke Correction strategies to manage deformations in head-and-neck radiotherapy Radiother Oncol 94 2010 199 205
97. H.P. van der Laan, E.W. Korevaar, W.V. Dolsma, J.H. Maduro, and J.A. Langendijk Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation Radiother Oncol 94 2010 235 240
98. M.H. Janssen, H.J. Aerts, and R.G. Kierkels Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: sequential perfusion-CT findings Radiother Oncol 94 2010 156 160
99. J.B. Van de Kamer, A.A. De Leeuw, M.A. Moerland, and I.M. Jürgenliemk-Schulz Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer Radiother Oncol 94 2010 248 253
100. T. Gupta, S. Jain, and J.P. Agarwal Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation Radiother Oncol 97 2010 194 199
101. D. Mak, D.L. Joon, and M. Chao The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer Radiother Oncol 97 2010 205 211
102. D. Thorwarth, and M. Alber Implementation of hypoxia imaging into treatment planning and delivery Radiother Oncol 97 2010 172 175
103. R.N. Moule, I. Kayani, and S.A. Moinuddin The potential advantages of (18)FDG PET/CT-based target volume delineation in radiotherapy planning of head and neck cancer Radiother Oncol 97 2010 189 193
104. H.J. Aerts, P. Lambin, and D.D. Ruysscher FDG for dose painting: a rational choice Radiother Oncol 97 2010 163 164
105. A.L. Grosu, and W.A. Weber PET for radiation treatment planning of brain tumours Radiother Oncol 96 2010 325 327
106. A. Chiti, M. Kirienko, and V. Grégoire Clinical use of PET-CT data for radiotherapy planning: what are we looking for? Radiother Oncol 96 2010 277 279
107. M. Lambrecht, and K. Haustermans Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors Radiother Oncol 96 2010 339 346
108. M. Coffey, and A. Vaandering Patient setup for PET/CT acquisition in radiotherapy planning Radiother Oncol 96 2010 298 301
109. R. Haubner PET radiopharmaceuticals in radiation treatment planning - synthesis and biological characteristics Radiother Oncol 96 2010 280 287
110. C. Haie-Meder, and R. Mazeron Magné N Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers Radiother Oncol 96 2010 351 355
111. B. Sattler, J.A. Lee, M. Lonsdale, and E. Coche PET/CT (and CT) instrumentation, image reconstruction and data transfer for radiotherapy planning Radiother Oncol 96 2010 288 297
112. M. Picchio, E. Giovannini, C. Crivellaro, L. Gianolli, N. di Muzio, and C. Messa Clinical evidence on PET/CT for radiation therapy planning in prostate cancer Radiother Oncol 96 2010 347 350
113. V. Gregoire, and A. Chiti PET in radiotherapy planning: particularly exquisite test or pending and experimental tool? Radiother Oncol 96 2010 275 276
114. V. Bettinardi, M. Picchio, N. Di Muzio, L. Gianolli, M.C. Gilardi, and C. Messa Detection and compensation of organ/lesion motion using 4D-PET/CT respiratory gated acquisition techniques Radiother Oncol 96 2010 311 316
115. E.G. Troost, D.A. Schinagl, J. Bussink, W.J. Oyen, and J.H. Kaanders Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours Radiother Oncol 96 2010 328 334
116. J.A. Lee Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology Radiother Oncol 96 2010 302 307
117. D. Thorwarth, X. Geets, and M. Paiusco Physical radiotherapy treatment planninǵbased on functional PET/CT data Radiother Oncol 96 2010 317 324
118. D. De Ruysscher, and C.M. Kirsch PET scans in radiotherapy planning of lung cancer Radiother Oncol 96 2010 335 338
119. W.A. Weber Quantitative analysis of PET studies Radiother Oncol 96 2010 308 310
120. I. Nawroth, J. Alsner, and M.A. Behlke Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFα prevents radiation-induced fibrosis Radiother Oncol 97 2010 143 148
121. J. Yarnold, and M.C. Brotons Pathogenetic mechanisms in radiation fibrosis Radiother Oncol 97 2010 149 161
122. L. Zhang, M. Yang, and N. Bi Association of TGF-β1 and XPD polymorphisms with severe acute radiation-induced esophageal toxicity in locally advanced lung cancer patients treated with radiotherapy Radiother Oncol 97 2010 19 25
123. H.B. Caglar, M. Othus, and A.M. Allen Esophagus in-field: a new predictor for esophagitis Radiother Oncol 97 2010 48 53
124. S.A. Bhide, S. Gulliford, and J. Fowler Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy Radiother Oncol 97 2010 86 91
125. S.X. Wu, T.T. Cui, and C. Zhao A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma Radiother Oncol 97 2010 113 118
126. T. Rosewall, C. Catton, and G. Currie The relationship between external beam radiotherapy dose and chronic urinary dysfunction - a methodological critique Radiother Oncol 2010 9740 9747
127. K. Koiwai, N. Shikama, S. Sasaki, A. Shinoda, and M. Kadoya Validation of the Total Dysphagia Risk Score (TDRS) as a predictive measure for acute swallowing dysfunction induced by chemoradiotherapy for head and neck cancers Radiother Oncol 97 2010 132 135
128. C.N. Andreassen Searching for genetic determinants of normal tissue radiosensitivity-are we on the right track? Radiother Oncol 97 2010 1 8
129. M. Hurmuzlu, K. Øvrebø, T. Wentzel-Larsen, L.P. Muren, A. Viste, and R. Smaaland High-dose preoperative chemoradiotherapy in esophageal cancer patients does not increase postoperative pulmonary complications: correlation with dose-volume histogram parameters Radiother Oncol 97 2010 60 64
130. N. Selo, T. Bölling, and I. Ernst Acute toxicity profile of radiotherapy in 690 children and adolescents: RiSK data Radiother Oncol 97 2010 119 126
131. L. Gothard, J. Haviland, and P. Bryson Randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema after radiotherapy for cancer Radiother Oncol 97 2010 101 107
132. M. Guckenberger, K. Baier, and B. Polat Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy Radiother Oncol 97 2010 65 70
133. Y. Maeda, M. Høyer, L. Lundby, S. Buntzen, and S. Laurberg Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy Radiother Oncol 97 2010 108 112
134. D.J. Farnell, P. Mandall, and C. Anandadas Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy Radiother Oncol 97 2010 136 142
135. E.F. Fidarova, D. Berger, and S. Schüssler Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses Radiother Oncol 97 2010 76 79
136. E. Alevronta, A. Ahlberg, and P. Mavroidis Dose-response relations for stricture in the proximal oesophagus from head and neck radiotherapy Radiother Oncol 97 2010 54 59
137. S. Martin, M. Sydenham, and J. Haviland Test of association between variant tgβ1 alleles and late adverse effects of breast radiotherapy Radiother Oncol 97 2010 15 18
138. M. Niemantsverdriet, E. de Jong, J.A. Langendijk, H.H. Kampinga, and R.P. Coppes Synergistic induction of profibrotic PAI-1 by TGF-β and radiation depends on p53 Radiother Oncol 97 2010 33 35
139. E. Ogo, R. Komaki, and T. Abe The clinical characteristics and non-steroidal treatment for radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy Radiother Oncol 97 2010 95 100
140. D. De Ruysscher, D. Severin, and E. Barnes First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II Radiother Oncol 97 2010 36 39
141. L. Perna, F. Alongi, and C. Fiorino Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy Radiother Oncol 97 2010 71 75
142. M. Trombetta, V. Valakh, T.B. Julian, E.D. Werts, and D. Parda Mammary fat necrosis following radiotherapy in the conservative management of localized breast cancer: does it matter? Radiother Oncol 97 2010 92 94
143. J.A. Langius, P. Doornaert, M.D. Spreeuwenberg, J.A. Langendijk, C.R. Leemans, and M.A. van der Schueren Radiotherapy on the neck nodes predicts severe weight loss in patients with early stage laryngeal cancer Radiother Oncol 97 2010 80 85
144. O. Zschenker, A. Raabe, and I.K. Boeckelmann Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity Radiother Oncol 97 2010 26 32
145. G.C. Barnett, C.E. Coles, and N.G. Burnet No association between SNPs regulating TGF-β1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study Radiother Oncol 97 2010 9 14
146. V. Valentini, F. Cellini, and B.D. Minsky Survival after radiotherapy in gastric cancer: systematic review and meta-analysis Radiother Oncol 92 2009 176 183
147. J. Lööf, D. Pfeifer, G. Adell, and X.F. Sun Significance of an exon 2 G4C14-to-A4T14 polymorphism in the p73 gene on survival in rectal cancer patients with or without preoperative radiotherapy Radiother Oncol 92 2009 215 220
148. J. Zhou, C.C. Hsu, and J.M. Winter Adjuvant chemoradiation versus surgery alone for adenocarcinoma of the ampulla of Vater Radiother Oncol 92 2009 244 248
149. M. Xi, M.Z. Liu, and L. Zhang How many sets of 4DCT images are sufficient to determine internal target volume for liver radiotherapy? Radiother Oncol 92 2009 255 259
150. M. Bouchard, R.A. Amos, T.M. Briere, S. Beddar, and C.H. Crane Dose escalation with proton or photon radiation treatment for pancreatic cancer Radiother Oncol 92 2009 238 243
151. J. Nijkamp, R. de Jong, J.J. Sonke, P. Remeijer, C. van Vliet, and C. Marijnen Target volume shape variation during hypo-fractionated preoperative irradiation of rectal cancer patients Radiother Oncol 92 2009 202 209
152. J.K. Bjerregaard, M.B. Mortensen, and H.A. Jensen Long-term results of concurrent radiotherapy and UFT in patients with locally advanced pancreatic cancer Radiother Oncol 92 2009 226 230
153. P. Hatfield, M. Hingorani, and G. Radhakrishna Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity Radiother Oncol 92 2009 210 214
154. O. Matzinger, E. Gerber, and Z. Bernstein EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach Radiother Oncol 92 2009 164 175
155. M. Kusters, F.A. Holman, and H. Martijn Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment Radiother Oncol 92 2009 221 225
156. C.D. Fuller, N.D. Dang, and S.J. Wang Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical results Radiother Oncol 92 2009 249 254
157. K. Bujko, P. Richter, and M. Kołodziejczyk Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders Radiother Oncol 92 2009 195 201
158. S. Mori, R. Hara, and T. Yanagi Four-dimensional measurement of intrafractional respiratory motion of pancreatic tumors using a 256 multi-slice CT scanner Radiother Oncol 92 2009 231 237
159. C.Y. Wang, M.J. Hsieh, and Y.C. Chiu Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy Radiother Oncol 92 2009 270 275
160. Y. Nishimura, M. Mitsumori, and M. Hiraoka A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021) Radiother Oncol 92 2009 260 265
161. M.B. Meng, Y.L. Cui, and Y. Lu Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis Radiother Oncol 92 2009 184 194
162. M. Onozawa, K. Nihei, and S. Ishikura Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus Radiother Oncol 92 2009 266 269